A cetylsalicylic acid (aspirin), introduced in medicine in 1899, is still one of the most commonly used analgesic, antipyretic, and anti-inflammatory drugs. In a new therapeutic use, based on its antiplatelet aggregation property, aspirin is used to treat cardiovascular complications (1) . Most of the absorbed aspirin reaches the systemic circulation as salicylate anion, reaching its maximal level in the blood serum 2 h after ingestion (2) . Therefore, plasma levels of salicylate are measured in patients to assess the effectiveness of therapy and to avoid side or toxic effects during long-term treatment.
Short-term analgesic/antipyretic doses of aspirin (25-50 mg/kg per day) produce only relatively low serum salicylate concentrations (30-100 mg/L) and almost never require therapeutic monitoring. In contrast, long-term anti-inflammatory doses of aspirin, which are given primarily to patients with various forms of arthritis, generally require laboratory monitoring to maintain serum salicylate within the therapeutic range, 150-300 mg/L serum. Because the difference between therapeutic and toxic dosages is relatively small, a rapid and specific method is needed to determine salicylate levels in the blood. Severe symptoms can be observed when salicylate levels in serum are >300 mg/L (2, 3).
Various methods for determining salicylate, which have been reported in the literature, make use of a large variety of analytical techniques. High-pressure liquid chromatography and gas-liquid chromatography (4-10), fluorescence (11, 12) , and ultraviolet spectrophotometry (13) have been used. The methods are highly sensitive, but many of these techniques require time-consuming sample pretreatment and are not suitable for use in emergency situations where a rapid test is required. Potentiometry analysis using ion-seletive electrodes (ISEs) has been used to determine salicylate in pharmaceutical samples (14, 15) and blood serum (16) . Common problems with the ISEs are interferences from anions normally present in biological fluids. In the clinical laboratory, colorimetric techniques are most popular and, of these, the Trinder test (17) is the most commonly used. The method is based on the formation of a colored complex when salicylate and iron(III) ions are combined. However the purple color in the weakly acid solution is nonspecific. A color reaction is obtained with a wide range of compounds found in body fluids, particularly phenols and aliphatic enols. For a more specific analysis, an enzymatic method is used (18) . The hydroxylation of the salicylate is catalyzed by salicylate hydroxylase (E.C. 1.14.13.1.), and this reaction can be used for analytical purposes. Although the enzymes are expensive and may increase the cost of the analysis, immobilization of the enzyme for repeated use significantly reduces the cost. The immobilization can be done on solid supports which are then packed in reactors (immobilized enzyme reactor; 19) or in close proximity to an electrode surface (20) (21) (22) .
This study describes a flow injection (FI) system with colorimetric detection for determination of salicylate in serum samples and in medicines. It is based on the generation of catechol by the passage of samples with salicylate and nicotinamide adenine dinucleotide (NADH) through a reactor containing salycilate hydroxylase immobilized in controlled porosity glass beads. The enzyme reaction of salicylate with NADH and oxygen, in the presence of salicylate hydroxylase, hydrolyzes salycilate, producing catechol, NAD + , carbon dioxide, and water ( Figure 1 ). In the enzymatic method described by Chubb et al. (23) , where enzyme is not immobilized, salicylate is converted to catechol, which is detected by formation of an indophenol dye with 4-aminophenol under alkaline conditions. The salicylate does not reacts with the dye. The light absorption of the complex formed is measured spectrophotometrically at 565 nm. Other aspirin metabolites analogous to salicylate, such as gentisic acid and salicyluric acid which are present in the blood at low levels, do not interfere in the assay (23) (24) (25) . According to Chubb et al. (23) , 54 common drugs were tested and only N-acetylcysteine and cysteamine interfered to about 10%.
In June 1998, Brazilians were surprised by an astonishing stream of falsification of medicines detected in contraceptives, prostate cancer medicines, and antibiotics. It was ascertained that the falsification included almost all kinds of pharmaceutical preparations, even very simple formulas such as analgesics and antipyretics. The situation still remains and there is strong evidence that such anomalies also occur in other countries (26, 27) . The specificity of the developed method was therefore tested in several pharmaceutical drugs containing acetylsalicylic acid. 
Experimental

Reagents
Enzyme Immobilization
The silanization and subsequent immobilization of the enzyme on the glass beads were performed as described by Zaitsev et al. (28) with some modifications. Glass beads (CPG 240; 0.2 g) were boiled in 10 mL 5% nitric acid for 30 min. The beads were filtered on a glass filter, washed several times with deionized water, and dried in an oven at 95°C. About 19 mL xylene (bp 137°-144°C), 1 mL 3-aminopropyltriethoxysilane, and 0.2 g glass beads were mixed in an Erlenmeyer flask. The mixture was heated for 3 h at 100°C. The glass beads were then washed with xylene and ethanol and dried at room temperature for 12 h. Then a treatment with the cross-linking agent glutaraldehyde (2.5% solution) was performed. The solution was prepared by diluting 25% glutaraldehyde solution in phosphate buffer (0.1M, pH 7.0). About 1 mL of the glutaraldehyde-buffer solution, enough to cover the beads, was added to the prepared alkylamino-glass beads. The reaction was allowed to proceed for 1 h at room temperature. Ten units of the enzyme salicylate hydroxylase were then weighed (0.93 units/mg solid) and dissolved in 3.0 mL cold phosphate buffer (0.1M, pH 7.6) and added to the alkylamino-glass. The mixture was allowed to stand at 4°C for 12 h. The immobilized enzyme was washed with phosphate buffer and then with cold water to remove any unlinked enzyme. The resulting immobilized enzyme was packed into a polyethylene tube 35 mm long and 3 mm in diameter. 
Apparatus and Manifold
(c) Sampling valve.-Described previously (29) . A schematic flow diagram for the colorimetric determination of salicylate is shown in Figure 2 .
Blood Serum Procedures
(a) Proposed enzymatic method.-The injected sample, not previously treated, containing salicylate and coenzyme, is combined with the carrier stream, a 0.1M phosphate buffer at pH 7.6 pumped at a flow rate of 0.6 mL/min. The whole mixture is then passed through the enzyme reactor. In the next path the mixture joins with the aminophenol solution and then with the sodium hydroxide solution.
(b) Trinder procedure.-A 10 g portion of Fe(NO 3 ) 3°9 H 2 O was dissolved in 1.0 L 0.1M HNO 3 . To 0.2 mL sample were added 0.8 mL water and 1.0 mL iron nitrate solution. The mixture was agitated and allowed to stand for 5 min. The light absorbance was measured in the spectrophotometer at 540 nm and compared with a calibration curve prepared in the same way. dissolved in ca 50 mL 0.5M NaOH solution, and gently boiled for 10 min. After the solution cooled to room temperature, the pH was adjusted to 7.0-7.8 by dropwise adding a solution 0.5M H 2 SO 4 and the solution was diluted with phosphate buffer (pH 7.6) according to the indications below. For tablets containing 0.5 g acetylsalicylic acid, the solution was diluted to 250 mL in a volumetric flask with the same buffer solution; 25 mL of this solution was diluted to 100.0 mL with buffer, and this solution was introduced in the FI system. For the infant tablet that contained ca 0.1 g acetylsalicylic acid, after dissolution with 0.5M NaOH, the solution was diluted to 100.0 mL with phosphate buffer. From this solution 10.0 mL was diluted to 50.0 mL with the buffer. This last solution was introduced in the FI system. The light absorption of the colored species formed was measured at 565 nm and registered on a chart recorder.
Medicines Procedures
Results and Discussion
To optimize the system, we investigated various parameters. Figure 3 shows that the signal height decreased almost linearly with the increase of the flow rate. As flow rate increases the time of contact of the salicylate with the enzyme decreases; thus less catechol is produced, leading to smaller signals. Slower rates, on the other hand, result in a poor sample throughput. Therefore, as a compromise between signal height and analytical frequency, a flow rate of 0.6 mL/min was chosen for the measurements.
The effect of pH was optimized for best activity of the enzyme. The optimum activity for free salicylate hydroxylase was at pH 7.6 and 30°C (20) . However, as the optimum pH could be changed by the immobilization process, the influence of pH on the immobilized enzyme was studied in the range of pH 7.0-8.0 (Figure 4) . The best results were found at pH 7.4-7.8. Therefore, pH 7.6 was chosen for the measurements.
The amount of the salicylate oxidized by the enzyme depends on the NADH concentration. The studied molar ratios between the concentrations of NADH and salicylate were 1:1, 2:1, 3:1, and 4:1. To obtain a good analytical signal, a molar ratio of NADH to salicylate equal to 3:1 is needed. Higher molar ratios do not improve the analytical response; therefore, the molar ratio 3:1 is a good compromise between the signal intensity and the cost of the analysis. Figure 5 shows the influence of the NADH/salicylate ratio on the intensity of the analytical signal. Figure 6 shows the effect of temperature on the reaction rate. The optimum activity of the immobilized enzyme was The nonlinearity of this calibration curve is attributed to the incompleteness of the conversion of the salicylate to cathecol. As the concentration of the sample increases, the nonconverted fraction gradually increases, leading to the obtained format of the curve.
If a straight line is preferred as a calibration curve, the equation h = 0.814 + 22.2 × 10 2 c can be used. However the correlation coefficient (0.996; n = 11) is a little lower than that obtained with the quadratic equation. Table 1 shows the results obtained with the 2 curves when salicylate is analyzed in blood serum. The mean of the recovery obtained with the quadratic curve presents a smaller standard deviation than that with the straight line treatment. However, both results are quite satisfactory, and the choice of the mathematical procedure can be based on the desired precision.
The stability of the enzyme reactor was measured daily for 30 days (Figure 9 ). The decrease of the activity is attributed to gradual degradation of the immobilized enzyme molecules. When not in use, the enzyme reactor was kept in a phosphate buffer in a refrigerator at 5°C. Table 1 shows the results obtained when this method was applied to previously untreated serum samples to which salicylate was added (standard addition method). The accuracy of the proposed method was quite satisfactory. Table 2 shows the results obtained with the proposed method and the Trinder method for 8 serum samples containing salicylate. The results obtained by the 2 methods were compared using the Student's t-test (31) , and showed good agreement with a degree of freedom (<) equal to 4 and a level of confidence (α) equal to 0.05 (95%). 
Conclusions
Because of its relative simplicity and low cost, the Trinder test currently is by far the most popular choice for salicylate analysis. However, enzymes are used in a range of analytical methods because of 2 characteristics: the unique specificity of the active site, and catalytic properties (32) . The method proposed in this work exhibits a relatively high reaction rate and specificity for the substrate (salicylate), characteristic of enzymatic reactions, with no interference from serum proteins. Furthermore, this method does not involve extraction, deproteinization, or derivatization.
The development and widespread use of immobilized enzymes are motivated by the need to reduce operative and cost constraints. Flow injection with integrated immobilized enzymes combines the advantages of enzymatic analysis and of FI, namely, reagent economy, operational simplicity, good analytical frequency, and specificity. Therefore it is recommended for use in the analysis of clinical samples and pharmaceutical products. 
